High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects (Q85054691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

D V Potsch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M L A Oliveira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Ginuíno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J C Miguel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

S A N Oliveira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

E F Silva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R B Moreira

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G V M Cruz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A L V S M Oliveira

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

L A B Camacho

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

P F Barroso

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

6 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

1447-1450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Sexual Transmission Efficiency of Hepatitis B Virus and Human Immunodeficiency Virus Among Homosexual Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Impaired response to recombinant hepatitis B vaccine in HIV-infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Hepatitis A and B Vaccination Practices for Ambulatory Patients Infected with HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Estimation of average concentration in the presence of nondetectable values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Criteria for successful hepatitis B vaccination in adults: results of a case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.066

10.1016/J.VACCINE.2009.11.066

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19995540%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference